$CSTE Income Statement | Understand Stock

$CSTE

$2.47 +$0.12 (5.11%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues
Cost of revenues
Gross profit
Operating expenses:
Research and development
Selling and marketing
General and administrative
Impairment of long lived assets, restructuring and other related costs
Legal settlements and loss contingencies, net
Total operating expenses
Operating loss
Finance expenses (income), net
Loss before taxes on income
Taxes on income
Net loss
Net loss attributable to non-controlling interest
Net Income Loss
Basic and diluted net income per share of Ordinary shares
Basic net loss per share of Ordinary shares
Diluted net loss per share of Ordinary shares
Weighted average number of Ordinary shares used in computing basic loss per share
Weighted average number of Ordinary shares used in computing diluted loss per share

Comments